Here we show that, in addition to increased risk for cerebrovascular disease (and other multi-systemic complications), patients with COL4A1 or COL4A2 mutations should be carefully monitored for progressive retinal neovascularization that could lead to sudden blindness. This evidence concerns the gene COL4A1 and cerebrovascular disorder.